A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer
Clinical trial NCT06431490 · RECRUITING
Trial details
- NCT number
- NCT06431490
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-22
- Primary completion
- 2027-05-01
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.